baber/WOPTO huggingface dataset:
Patent EP-3821989-A1 (EP)
Inventor: TANG XIAOFENG
IPC: G01R33/12
Filed: 2019-07-02
Abstract: An online automatic measurement system for a claw-pole overall magnetic property comprising: a feeding part, a claw-pole overall magnetic property measurement unit, and a discharging part disposed in sequence, and a robotic arm disposed there among. The robotic arm receives an operation instruction output by a control unit to grab claw poles to be measured in sequence and removes measured claw poles on the claw-pole overall magnetic property measurement unit. The claw-pole overall magnetic property measurement unit outputs a control power supply to the claw-pole overall magnetic property measurement unit according to the instruction of the control unit, receives an induction current of the measured claw poles, and output a measurement result to the control unit. The system significantly improves the measurement efficiency of a claw pole part by means of a full-automatic measurement process.
Patent EP-3823035-A1 (EP)
Inventor: LI SIMIN
IPC: H01L29/745
Filed: 2019-07-02
Abstract: A gate turn-off thyristor. A plurality of strips consisting of a plurality of repeatedly arranged top-transistor N-type emitting regions (3) having a high doping concentration are provided on the upper surface of an N-type high-resistivity silicon substrate (12); each strip is surrounded by top-transistor P-type concentrated base region bus bars (5); a cathode metal layer (1) is provided above each top-transistor N-type emitting region (3), and an top-transistor P-type base region (2) is provided below each top-transistor N-type emitting region (3); a side surface of the top-transistor P-type base region (2) is connected to an top-transistor P-type concentrated base region (6) or the top-transistor P-type concentrated base region bus bar (5) having a higher doping concentration than the top-transistor P-type base region (2); an top-transistor N-type collector region (4) is provided below each of the top-transistor P-type base region (2); the top-transistor P-type concentrated base region (6), and the top-transistor P-type concentrated base region bus bar (5); a bottom-transistor P-type emitting region (11) is provided under the top-transistor N-type collector region (4); the bottom-transistor P-type emitting region (11) is located at the bottom of the silicon substrate (12); the lower surface of the bottom-transistor P-type emitting region (11) is connected to an anode metal layer (8); a gate metal layer (10) is provided above the silicon substrate (12); the top-transistor P-type concentrated base region (6) intersects or is parallel with the top-transistor P-type concentrated base region bus bar (5); the upper surface of the top-transistor P-type concentrated base region bus bar (5) is connected to the gate metal layer (10); the repeating interval between adjacent top-transistor N-type emitting regions (3) in each strip is within 50 µm; and a die of the gate turn-off thyristor is a square die.
Patent EP-3897647-A1 (EP)
Title: Combinations of a hdm2-p53 interaction inhibitor and a bcl2 inhibitor and their use for treating cancer
Inventor: GUERREIRO NELSON
IPC: A61P35/02
Filed: 2019-12-18
Abstract: The present invention relates to the combination of the HDM2-p53 interaction inhibitor drug (S)-5-(5-Chloro-1-methyl-2-oxo-1,2-dihydro-pyridin-3-yl)-6-(4-chloro-phenyl)-2-(2,4-dimethoxy-pyrimidin-5-yl)-1-isopropyl-5,6-dihydro-1H-pyrrolo[3,4-d]imidazol-4-one [HDM201] and the BCL2 inhibitor 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-[(3-nitro-4-{[(oxan-4yl)methyl]amino}phenyl)sulfonyl]-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide [venetoclax]. The present invention further relates to the use of said combination in the treament of cancer, in particular hematological tumors. The present invention further relates to dose and dosing regimen related to this combination cancer treatment.
Patent EP-3833350-A1 (EP)
Inventor: JACOBSEN ERIC
IPC: C07D403/14
Filed: 2019-08-12
Abstract: Disclosed herein are arylpyridinone compounds and compositions useful in the treatment of ITK mediated diseases, such as inflammation, having the structures of Formulas (I) -(IV): wherein the R groups, m, n, and X are as defined in the detailed description. Methods of inhibition of ITK activity in a human or animal subject are also provided.
Patent EP-3831926-A1 (EP)
Inventor: IWAKAMI Masashi
IPC: C12M3/00
Filed: 2019-08-06
Abstract: A cell culture system for dividing and subculturing cell aggregates is constituted by connecting a first container 10 and a divider 20. An outlet of a divider is connected to the first container. A mesh structure 22 for dividing a cell aggregate is provided in a conduit for dividing in the divider 20, and a cell aggregate is divided while passing through the mesh structure. The divided cell aggregate is sent to the first container 10 without contacting the outside air in a preferred embodiment, where further culture is performed. This makes it possible to divide the cell aggregate and perform suspension culture while maintaining the closed system. The division and suspension culture of cell aggregates can be repeated by sending the cultured cell aggregates to a divider of its own cell culture system or a divider of a cell culture system prepared separately.
Patent EP-3674763-A1 (EP)
Inventor: WANG YULIANG
IPC: G02B6/44
Filed: 2019-09-27
Abstract: The present invention provides an integrated optical cable having a simple and compact structure designed in an integrated way, which can be applied to a variety of indoor and outdoor scenarios to meet most needs. The integrated optical cable comprises an optical fiber, a sheath provided outside the optical fiber, and a reinforcement layer further provided between the optical fiber and the sheath. The reinforcement layer is made of a high-modulus LCP material, and the tensile modulus of the LCP material is greater than 10 GPa. Meanwhile, the invention further provides a manufacturing process of the integrated optical cable, comprising storing optical fiber, coloring optical fiber, coating, sheathing, and leaving the factory.
Patent EP-3845654-A1 (EP)
Inventor: TAKE Chihiro
IPC: C12N5/10
Filed: 2019-08-30
Abstract: The present invention provides immune cells (such as CAR-T cells) having higher antitumor activity than immune cells (such as CAR-T cells) expressing a CAR alone (not expressing cytokines and/or chemokines). A T cell provided in one aspect of the present invention expresses (1) a chimeric antigen receptor (CAR), (2) at least one selected from the group consisting of interleukin-15 (IL-15), interleukin-18 (IL-18), interleukin-21 (IL-21), and interleukin-27 (IL-27), and (3) CC chemokine ligand 19 (CCL19).
Patent EP-3808878-A1 (EP)
Inventor: NAKAGAWA YUSUKE
IPC: C25D5/50
Filed: 2019-06-07
Abstract: It is an object to provide a steel sheet for can making, the steel sheet being excellent in weldability and post-working corrosion resistance, and a method for manufacturing the same. 
     A steel sheet for can making includes an iron-nickel diffusion layer, a metallic chromium layer, and a chromium oxide layer on at least one surface of the steel sheet in order from the steel sheet side. The iron-nickel diffusion layer has a nickel coating weight of 50 mg/m 2  to 500 mg/m 2  per surface of the steel sheet and a thickness of 0.060 µm. to 0.500 µm per surface of the steel sheet. The metallic chromium layer includes a flat-like metallic chromium sublayer and a granular metallic chromium sublayer placed on a surface of the flat-like metallic chromium sublayer. The total chromium coating weight of both per surface of the steel sheet is 60 mg/m 2  to 200 mg/m 2 . The granular metallic chromium sublayer further includes granular protrusions having a number density of 5 µm -2  or more per unit area and a maximum diameter of 150 nm or less. The chromium oxide layer has a chromium coating weight 3 mg/m 2  to 10 mg/m 2  per surface of the steel sheet in terms of metallic chromium.
Patent EP-3851858-A1 (EP)
Inventor: HIROKI Kohei
IPC: G01N35/00
Filed: 2019-08-21
Abstract: Provided is an automatic analysis device that can suppress concentration of a reagent made to react with a specimen. This automatic analysis device is provided with: a reagent container which accommodates a reagent and which has attached thereto a perforable lid; a perforation unit for perforating the lid; and a reagent suction nozzle that is inserted into a hole formed by perforation and that sucks up the reagent. The automatic analysis device is characterized by being further provided with a state storage unit that stores the state as to whether the reagent container is in an unused state or in a used state, and a state update unit that, when the lid is perforated by the perforation unit while the reagent container is in an unused state, updates the state stored in the state storage unit to the used state.
Patent EP-3762823-A1 (EP)
Title: Détermination de politiques de sélection d'actions d'un dispositif d'exécution
Inventor: LI HUI
IPC: G06F9/455
Filed: 2019-05-15
Abstract: L'invention concerne des procédés, des systèmes et des appareil permettant de générer une politique de sélection d'action (ASP) pour un dispositif d'exécution. Un procédé consiste à obtenir une ASP lors d'une itération actuelle ; à obtenir une première récompense respective pour chaque action dans un état actuel ; à calculer une première récompense de l'état actuel, en fonction des premières récompenses respectives pour les actions et pour l'ASP ; à calculer une valeur de régression respective de chaque action, en fonction d'une différence entre la première récompense respective pour l'action et la première récompense pour l'état actuel ; à calculer une ASP incrémentielle en fonction de la valeur de régression respective de chaque action dans l'itération actuelle ; à calculer une seconde récompense pour l'état actuel en fonction de l'ASP incrémentielle ; à déterminer une ASP lors d'une itération suivante en fonction de la seconde récompense de l'état actuel ; et à commander des actions du dispositif d'exécution selon l'ASP.
Patent EP-3857173-A1 (EP)
Inventor: HOLMSTADT CLARENCE E
IPC: G01K1/14
Filed: 2019-09-25
Abstract: L'invention concerne un émetteur de processus(100) comprenant un boîtier d'émetteur (108) et un détecteur de liquide (128, 302) couplé au boîtier d'émetteur (108). Le détecteur de liquide (128, 302) comprend un capteur de température (402) configuré pour générer des signaux indicatifs d'une présence de liquide dans le boîtier d'émetteur (108). L'émetteur de processus (100) comprend également un dispositif de commande (122) couplé au détecteur de liquide (128, 302) configuré pour recevoir les signaux générés, déterminer la présence de liquide dans le boîtier d'émetteur (108) sur la base des signaux reçus, et générer une sortie indicative de la présence déterminée de liquide à l'intérieur du boîtier d'émetteur (108).
Patent EP-3891092-A1 (EP)
Inventor: DUPEYRON NICOLAS
IPC: B66F9/06
Filed: 2019-12-05
Abstract: The invention relates to a collaborative system for handling any load (12) on a handling surface (11), comprising a fleet of mobile handling robots (100; 200; 300; 400; 500; 600), each comprising a chassis (101), members for moving the chassis on said handling surface (11) and means for lifting said load carried by said chassis (101), said system further comprising: a control unit (142) configured to be able to provide to a master robot (100) reference commands of said lifting means and said movement members of said robot; and synchronization means (130,136, 138, 139) of said robots configured to be able to provide to each slave robot (200; 300; 400; 500; 600) commands derived from said lifting means and said movement members of said slave robot determined from said reference commands of said master robot (100), in order to enable collaborative handling of said load (12).
Patent EP-3861978-A1 (EP)
Inventor: JUN SEUNG HYUN
IPC: A61K8/02
Filed: 2019-06-04
Abstract: A makeup base cosmetic composition for skin according to the present invention comprises biocellulose microfibrils, such that color cosmetics applied on the skin can be easily cleansed due to a dense network of a three-dimensional network structure formed by the microfibrils.
Patent EP-3866846-A1 (EP)
Inventor: HEROLD BETSY
IPC: C07K16/40
Filed: 2019-10-17
Abstract: Methods of preferentially enhancing in a subject an antibody-dependent cell-mediated cytotoxicity (ADCC) antibody response over a neutralizing antibody response to a vaccine for an infectious agent using herpesvirus entry mediator (HVEM) agonists, and related compositions.
Patent EP-3867483-A1 (EP)
Inventor: REID FRÉDÉRICK
IPC: E06C9/06
Filed: 2019-10-25
Abstract: A self-retractable step for assisting a user in elevating him or herself above a floor, is disclosed. The self-retractable step comprises a self-retractable foot member and a cylindrical assembly coupled with the self-retractable foot member. The foot member is configured to move from one position to another position. The cylindrical assembly comprises a rotary member, one or more spring members and a protuberance member. The rotary member is configured to move the foot member to a predetermined position. Further, the spring members coupled to the rotary member is configured to self-retract the foot member from the predetermined position. The protuberance member disposed at the cylindrical assembly is configured to act as a stopper to hold the foot member in a predetermined position on retraction by the spring members. The self-retractable step further comprises a load bearing member at a base of the foot member.
Patent EP-3698182-A1 (EP)
Inventor: SHEPARD RALPH HAMILTON
IPC: G02B5/20
Filed: 2019-10-28
Abstract: Un exemple de système comprend une lentille disposée par rapport à une scène et conçue pour focaliser la lumière provenant de la scène. Le système comprend également un matériau opaque. Le matériau opaque définit une pluralité d'ouvertures comprenant une ouverture primaire et une ou plusieurs ouverture(s) secondaire(s). Le système comprend également un ou plusieurs détecteur(s) de lumière (par exemple, un détecteur à élément unique ou un réseau de détecteurs) configuré(s) pour intercepter et détecter une lumière divergente focalisée par la lentille et transmise à travers au moins l'une de la pluralité d'ouvertures définies par le matériau opaque.
Patent EP-3868828-A1 (EP)
Inventor: YANG YAN
IPC: C08L53/02
Filed: 2019-10-30
Abstract: The present invention discloses a high weld line strength polypropylene/polycarbonate alloy, including the following components in parts by weight: 5 parts to 40 parts of a polypropylene; 40 parts to 85 parts of a polycarbonate; and 1 part to 15 parts of an ethylene copolymer compatibilizer. The high weld line strength polypropylene/polycarbonate alloy has high weld line strength, a good melt index and an excellent chemical resistance.
Patent EP-3880689-A1 (EP)
Inventor: GAETA FEDERICO
IPC: C09K15/18
Filed: 2019-11-14
Abstract: Disclosed is nucleic acid preserving compositions and methods of manufacturing and using the same. Compositions include a carrier, a chaotropic agent, a buffering agent, a chelating agent, a surfactant, an alcohol, and a reducing agent. Compositions as aqueous solutions can include water as a carrier. Preferred embodiments include RNAse-free water, lithium chloride, sodium citrate, EDTA, CTAB or SLS, SDA 3C, and TCEP, with HCl optionally added to adjust pH. Some embodiments include a colored dye as a visual indicator. Methods of manufacturing include combining the components into a mixture, such as an aqueous solution. Methods of use include providing a biological sample that includes nucleic acid, preferably RNA, and contacting the biological sample with the composition. Kits include a biological sample collection apparatus and the composition. The composition is optionally disposed in a portion of the collection apparatus.
Patent EP-3885746-A1 (EP)
Inventor: SATO TAKASHI
IPC: G01N1/28
Filed: 2019-11-21
Abstract: A single-crystal X-ray structure analysis system capable of surely and easily performing a precise step of soaking a very small amount of a sample in a framework of a fine crystalline sponge, is provided. There are provided a soaking apparatus 500 and a single-crystal X-ray structure analysis apparatus, the single-crystal X-ray structure analysis apparatus comprising an X-ray source that generates X-rays; a sample holder that holds a sample, the sample holder comprising a porous complex crystal capable of soaking the sample in a plurality of fine pores formed therein; a goniometer that rotationally moves, the goniometer to which the sample holder is attached; an X-ray irradiation section that irradiates the X-rays from the X-ray source to the sample held by the sample holder attached to the goniometer; an X-ray detection measurement section that detects and measures X-rays diffracted or scattered by the sample; and a structure analysis section that performs a structure analysis of the sample based on the diffracted or scattered X-rays detected by the X-ray detection measurement section, wherein the soaking apparatus 500 soaks the sample in the porous complex crystal of the sample holder.
Patent EP-3874213-A1 (EP)
Inventor: SCALF ERIC
IPC: F25D23/12
Filed: 2019-07-02
Abstract: A variable ice dispenser (112) for a refrigerator (10) utilizes a variable control (128) suitable for varying the rate of ice dispensing by the dispenser (112). The variable control (128) includes a variable control actuator (130) that is movable between a range of positions including a home position, and movement of the variable control actuator (130) in a first direction from the home position causes the variable ice dispenser (112) to dispense cubed ice while movement of the variable control actuator (130) in a second direction from the home position causes the variable ice dispenser (112) to dispense crushed ice. The variable control (128) may also selectively activate the ice dispenser (112) such that the variable control actuator (130) controls the ice dispensing rate while the variable ice dispenser (112) is activated. The variable control (128) may also include a secondary control (132) that switches between ice and water dispensing modes.
Patent EP-3897386-A1 (EP)
Inventor: Campbell Luke John
IPC: H04S7/00
Filed: 2019-12-20
Abstract: Introduced here are systems and methods to enable recording artists and engineers to specify exactly how the audio track should be played as well as perceived by the user in the case where the frequency transfer functions of the sound playback system and/or listening mechanisms (user's own hearing) can be measured and compensated for. For example, the acoustic environment during recording and mastering can be measured, and the measurements can be recorded in an inaudible portion of an audio track. The acoustic environment can include speaker frequency, distortion, reverberation, channel separation, room acoustics, etc. In addition, a hearing profile of the audio creator, such as the recording artist, sound engineer, mastering person, etc., can be included within the inaudible data. Further, the acoustic environment and/or the hearing profile of the audio consumer can also be used to modify the audio prior to reproducing the audio to the audio consumer.
Patent EP-3903872-A1 (EP)
Inventor: ZHANG TINGCHAO
IPC: A61M25/14
Filed: 2019-09-19
Abstract: A bendable catheter (100) is provided and includes a tube body (10) and a traction member (30). The tube body (10) includes a bendable section (11) arranged at a distal end of the tube body (10). The traction member (30) includes a traction wire (31) , a threading tube (32), a protective casing (33), and a clamping tube (34). The traction wire (31) has a distal end connected to the bendable section (11), a proximal end wrapped and fixed within the clamping tube (34), and a remainder which is sequentially moveably threaded in the threading tube (32) and the protective casing (33) in a direction from the distal end of the tube body (10) to a proximal end of the tube body (10). A proximal end of the threading tube (32) is relatively fixed with a distal end of the protective casing (33) without a gap in axial directions of the threading tube (32) and the protective casing (33), and a distal end of the clamping tube (34) is movably threaded in the protective casing (33). The clamping tube (34) is operable to move in the protective casing (33) to drive the traction wire (31) to move in the protective casing (33) and the threading tube (32), so as to bend or straighten the bendable section (11). An inner cavity of the protective casing (33) limits a degree of bending deformation of the traction wire (31), and can prevent the traction wire (31) from being severely bent or broken near the proximal end of the threading tube (32), thereby ensuring smooth implementation of the bend adjusting function of the bendable catheter (100).
Patent EP-3841426-A1 (EP)
Inventor: LEE KYOOKEUN
IPC: G02F1/1335
Filed: 2019-12-24
Abstract: Provided are an optical device and a method of outputting light using the optical device. The optical device includes a waveguide, a first diffraction grating receiving at least a portion of light incident on the waveguide and a second diffraction grating receiving a light diffracted from the first diffraction grating,, wherein the first diffraction grating and the second diffraction grating are provided in or on the waveguide, the light diffracted from the first diffraction grating is diffracted, in three-dimensional directions, from the second diffraction grating, and at least a portion of the light diffracted in the three-dimensional directions is output to an outside of the waveguide.
Patent EP-3888649-A1 (EP)
Inventor: LI XIANGDONG
IPC: A61P17/02
Filed: 2019-01-24
Abstract: The present invention belongs to the field of medicine, and relates to use of cannflavin A in preparation of a drug for promoting wound healing. Particularly, the present invention relates to use of cannflavin A in preparation of a drug for promoting wound healing of type II diabetes. Cannflavin A can effectively promote wound healing, and has the potential to prepare a drug for promoting wound healing, especially for preventing and treating diabetic feet.
Patent EP-3949971-A1 (EP)
Title: Use of luteolin-7-o-glucoside or luteolin-7-o-glucuronide in preparation of medicine for eye injuries
Inventor: WANG HAO
IPC: A61K31/7048
Filed: 2019-08-20
Abstract: Provided is the use of luteolin-7-O-glucoside or luteolin-7-O-glucuronide in the preparation of a medicine for eye injuries, wherein same falls within the technical field of medicines. Further provided is the use of luteolin-7-O-glucoside and/or luteolin-7-O-glucuronide in the preparation of a medicine for treating eye injuries caused by blue light. An in vitro drug effect screening model experiment of blue light-induced damage of retinal pigment epithelial cells proves that the luteolin-7-O-glucoside and luteolin-7-O-glucuronide have an efficacy in protecting retinal pigment epithelial cells from damage caused by blue light. Therefore, the luteolin-7-O-glucoside and lutecolin-7-O-glucuronide may also be used in eye-protection health products or foods.